anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 13.10.16 | Roche overweight | Morgan Stanley | |
| 13.10.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.10.16 | Roche buy | Jefferies & Company Inc. | |
| 12.10.16 | Roche buy | Deutsche Bank AG | |
| 10.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 04.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.16 | Roche overweight | JP Morgan Chase & Co. | |
| 15.09.16 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 14.09.16 | Novartis Neutral | BNP PARIBAS | |
| 14.09.16 | Roche Outperform | BNP PARIBAS | |
| 13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 12.09.16 | Roche buy | Jefferies & Company Inc. | |
| 08.09.16 | Roche buy | Société Générale Group S.A. (SG) | |
| 02.09.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.08.16 | Roche buy | Baader Wertpapierhandelsbank | |
| 17.08.16 | Roche buy | Deutsche Bank AG | |
| 11.08.16 | Novartis buy | Kepler Cheuvreux | |
| 08.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Roche overweight | Morgan Stanley | |
| 04.08.16 | Roche buy | Jefferies & Company Inc. | |
| 04.08.16 | Novartis buy | Jefferies & Company Inc. | |
| 04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 27.07.16 | Roche buy | Citigroup Corp. | |
| 26.07.16 | Roche overweight | Morgan Stanley | |
| 22.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 22.07.16 | Roche Outperform | Bernstein Research | |
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis Outperform | Bernstein Research | |
| 20.07.16 | Novartis Neutral | UBS AG | |
| 20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. |
